# Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer

> clinical trial · VERIFIED · 2026-07-06

Status: RECRUITING · Sponsor: Beijing Daxiang Biotech Co., Ltd · Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

- Company: Beijing Daxiang Biotech Co., Ltd
- Sector: Pancreatic Ductal Adenocarcinoma (PDAC)
- Primary source: https://clinicaltrials.gov/study/NCT07683845

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.